Kamran Mirza, MD, FCAP, discusses molecular hematopathology. “The landscape of molecular diagnostics in hematopathology has undergone significant transformation due to advancements in next-generation sequencing (NGS) technologies, the development of targeted therapies, and the increasing understanding of the genetic basis of hematologic malignancies,” said Dr. Mirza.
For the full article click here: Molecular Mysteries in the Blood *Subscription needed*